Christopher D. Hillyer

Christopher D. Hillyer, MD, President and CEO of New York Blood Center (NYBC) and Professor, Department of Medicine, Weill Cornell Medical College, New York, New York, was previously the tenured, endowed Distinguished Service Professor, Department of Pathology and Laboratory Medicine, Emory University School of Medicine and served as director of the Emory Center for Transfusion and Cellular Therapies with responsibility for all aspects of clinical and academic transfusion medicine. He is a co-founder of the companies Transfusion & Transplantation Technologies, Inc. (3Ti), and HemeXcel Purchasing Alliance, and HemeXcel Resources, holds a number of patents or patents pending for devices and processes related to blood banking, transfusion medicine, and cellular therapies.

Dr. Hillyer is board certified in transfusion medicine, hematology, medical oncology, and internal medicine. He received his BS with honors from Trinity College and his MD from the University of Rochester School of Medicine, with postgraduate training and fellowships in hematology-oncology, transfusion medicine, and bone marrow transplantation at Tufts-New England Medical Center in Boston.